A	O
Hydrogel	O
Model	O
Incorporating	O
3D	O
-	O
Plotted	O
Hydroxyapatite	O
for	O
Osteochondral	O
Tissue	O
Engineering	O

The	O
concept	O
of	O
biphasic	O
or	O
multi	O
-	O
layered	O
compound	O
scaffolds	O
has	O
been	O
explored	O
within	O
numerous	O
studies	O
in	O
the	O
context	O
of	O
cartilage	O
and	O
osteochondral	O
regeneration	O
.	O

To	O
date	O
,	O
no	O
system	O
has	O
been	O
identified	O
that	O
stands	O
out	O
in	O
terms	O
of	O
superior	O
chondrogenesis	O
,	O
osteogenesis	O
or	O
the	O
formation	O
of	O
a	O
zone	O
of	O
calcified	O
cartilage	O
(	O
ZCC	O
).	O

Herein	O
we	O
present	O
a	O
3D	O
plotted	O
scaffold	O
,	O
comprising	O
an	O
alginate	O
and	O
hydroxyapatite	O
paste	O
,	O
cast	O
within	O
a	O
photocrosslinkable	O
hydrogel	O
made	O
of	O
gelatin	O
methacrylamide	O
(	O
GelMA	O
),	O
or	O
GelMA	O
with	O
hyaluronic	O
acid	O
methacrylate	O
(	O
HAMA	O
).	O

We	O
hypothesized	O
that	O
this	O
combination	O
of	O
3D	O
plotting	O
and	O
hydrogel	O
crosslinking	O
would	O
form	O
a	O
high	O
fidelity	O
,	O
cell	O
supporting	O
structure	O
that	O
would	O
allow	O
localization	O
of	O
hydroxyapatite	O
to	O
the	O
deepest	O
regions	O
of	O
the	O
structure	O
whilst	O
taking	O
advantage	O
of	O
hydrogel	O
photocrosslinking	O
.	O

We	O
assessed	O
this	O
preliminary	O
design	O
in	O
terms	O
of	O
chondrogenesis	O
in	O
culture	O
with	O
human	B-OG
articular	O
chondrocytes	O
,	O
and	O
verified	O
whether	O
the	O
inclusion	O
of	O
hydroxyapatite	O
in	O
the	O
form	O
presented	O
had	O
any	O
influence	O
on	O
the	O
formation	O
of	O
the	O
ZCC	O
.	O

Whilst	O
the	O
inclusion	O
of	O
HAMA	O
resulted	O
in	O
a	O
better	O
chondrogenic	O
outcome	O
,	O
the	O
effect	O
of	O
HAP	O
was	O
limited	O
.	O

We	O
overall	O
demonstrated	O
that	O
formation	O
of	O
such	O
compound	O
structures	O
is	O
possible	O
,	O
providing	O
a	O
foundation	O
for	O
future	O
work	O
.	O

The	O
development	O
of	O
cohesive	O
biphasic	O
systems	O
is	O
highly	O
relevant	O
for	O
current	O
and	O
future	O
cartilage	O
tissue	O
engineering	O
.	O

1	O
.	O

Introduction	O

Articular	O
cartilage	O
is	O
a	O
complex	O
tissue	O
,	O
organized	O
into	O
a	O
zonal	O
structure	O
with	O
varied	O
biochemical	O
and	O
biomechanical	O
properties	O
throughout	O
each	O
zone	O
.	O

Cartilage	O
matrix	O
is	O
rich	O
in	O
collagens	B-GP
and	O
proteoglycans	O
,	O
with	O
the	O
dominant	O
collagen	B-GP
type	O
(>	O
90	O
%)	O
being	O
collagen	B-GP
type	I-GP
II	I-GP
[	O
1	O
].	O

The	O
zones	O
of	O
cartilage	O
vary	O
with	O
depth	O
,	O
with	O
collagen	B-GP
fiber	O
orientation	O
and	O
chondrocyte	O
morphology	O
changing	O
throughout	O
the	O
tissue	O
,	O
from	O
the	O
superficial	O
layer	O
(	O
fibers	O
parallel	O
to	O
surface	O
,	O
flattened	O
cell	O
morphology	O
),	O
to	O
the	O
transitional	O
layer	O
(	O
fibers	O
randomly	O
oriented	O
,	O
rounded	O
cell	O
morphology	O
)	O
and	O
finally	O
the	O
deep	O
layer	O
(	O
fibers	O
perpendicular	O
to	O
surface	O
,	O
columnar	O
cell	O
alignment	O
).	O

The	O
zone	O
of	O
calcified	O
cartilage	O
(	O
ZCC	O
)	O
is	O
found	O
beyond	O
the	O
deepest	O
part	O
of	O
cartilage	O
,	O
linking	O
the	O
cartilage	O
to	O
the	O
subchondral	O
bone	O
.	O

The	O
ZCC	O
varies	O
considerably	O
from	O
the	O
cartilage	O
,	O
for	O
instance	O
in	O
collagen	B-GP
II	I-GP
content	O
:	O
~	O
60	O
%	O
dry	O
weight	O
in	O
cartilage	O
versus	O
~	O
20	O
%	O
in	O
the	O
ZCC	O
[	O
2	O
].	O

Further	O
,	O
the	O
percentage	O
of	O
hydroxyapatite	O
(	O
HAP	O
)	O
in	O
the	O
ZCC	O
by	O
dry	O
weight	O
is	O
~	O
65	O
%,	O
comparable	O
with	O
that	O
of	O
subchondral	O
bone	O
at	O
~	O
86	O
%	O
[	O
2	O
].	O

The	O
ZCC	O
is	O
also	O
rich	O
in	O
collagen	B-GP
X	I-GP
,	O
which	O
is	O
absent	O
from	O
hyaline	O
cartilage	O
[	O
3	O
].	O

It	O
is	O
overall	O
a	O
transitional	O
tissue	O
,	O
providing	O
a	O
gradient	O
of	O
mechanical	O
properties	O
between	O
the	O
more	O
compliant	O
articular	O
cartilage	O
and	O
the	O
stiffer	O
underlying	O
bone	O
tissue	O
[	O
3	O
].	O

As	O
intrinsic	O
cartilage	O
repair	O
is	O
poor	O
,	O
numerous	O
strategies	O
for	O
regeneration	O
have	O
emerged	O
,	O
such	O
as	O
the	O
tissue	O
engineering	O
of	O
cartilage	O
scaffolds	O
[	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
].	O

This	O
approach	O
predominantly	O
revolves	O
around	O
the	O
use	O
of	O
hydrogels	O
,	O
highly	O
hydrated	O
and	O
diffusive	O
polymer	O
matrices	O
which	O
provide	O
nutrient	O
exchange	O
and	O
a	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
matrix	O
whilst	O
also	O
providing	O
a	O
desired	O
chondromimetic	O
hypoxic	O
environment	O
[	O
8	O
,	O
9	O
].	O

3D	O
-	O
printing	O
/	O
plotting	O
has	O
also	O
been	O
used	O
in	O
tissue	O
engineering	O
of	O
cartilage	O
or	O
osteochondral	O
defects	O
,	O
wherein	O
deposition	O
of	O
a	O
polymer	O
(	O
melt	O
or	O
hydrogel	O
)	O
[	O
10	O
,	O
11	O
]	O
and	O
/	O
or	O
ceramic	O
paste	O
(	O
in	O
the	O
case	O
of	O
osteochondral	O
scaffolds	O
)	O
[	O
12	O
,	O
13	O
]	O
is	O
used	O
to	O
form	O
a	O
mesh	O
-	O
type	O
structure	O
on	O
a	O
computer	O
-	O
controlled	O
stage	O
,	O
resulting	O
in	O
a	O
scaffold	O
structure	O
with	O
a	O
desired	O
morphology	O
.	O

Whilst	O
hydrogel	O
matrices	O
are	O
highly	O
suited	O
to	O
work	O
towards	O
cartilage	O
regeneration	O
,	O
bridging	O
the	O
gap	O
into	O
engineering	O
full	O
osteochondral	O
defects	O
is	O
difficult	O
and	O
more	O
complex	O
[	O
12	O
].	O

Herein	O
we	O
focus	O
on	O
the	O
development	O
of	O
a	O
novel	O
scaffold	O
system	O
constructed	O
using	O
a	O
combination	O
of	O
3D	O
plotting	O
and	O
gel	O
casting	O
with	O
photopolymerization	O
.	O

Gelatin	O
,	O
commonly	O
produced	O
through	O
hydrolysis	O
of	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
collagens	B-GP
such	O
as	O
those	O
found	O
in	O
bone	O
and	O
skin	O
,	O
retains	O
desired	O
matrix	B-GP
metalloproteinase	I-GP
(	O
MMP	B-GP
)-	O
sensitive	O
degradation	O
sites	O
and	O
cell	O
binding	O
motifs	O
such	O
as	O
Arg	O
-	O
Gly	O
-	O
Asp	O
(	O
RGD	O
)	O
[	O
14	O
].	O

It	O
is	O
also	O
chemically	O
modifiable	O
,	O
yielding	O
a	O
photocrosslinkable	O
hydrogel	O
gelatin	O
methacrylamide	O
(	O
GelMA	O
)	O
[	O
15	O
].	O

Hyaluronic	O
acid	O
(	O
HA	O
),	O
the	O
most	O
abundant	O
glycosaminoglycan	O
(	O
GAG	O
)	O
found	O
in	O
cartilage	O
,	O
is	O
also	O
similarly	O
modifiable	O
(	O
hyaluronic	O
acid	O
methacrylate	O
,	O
HAMA	O
)	O
and	O
has	O
been	O
shown	O
to	O
promote	O
chondrogenic	O
differentiation	O
in	O
vitro	O
[	O
16	O
].	O

In	O
this	O
work	O
,	O
we	O
print	O
grid	O
scaffolds	O
made	O
of	O
an	O
alginate	O
/	O
HAP	O
paste	O
to	O
form	O
a	O
ZCC	O
and	O
combine	O
these	O
with	O
a	O
GelMA	O
±	O
HAMA	O
hydrogel	O
system	O
through	O
ultraviolet	O
(	O
UV	O
)	O
photopolymerization	O
.	O

We	O
hypothesize	O
that	O
such	O
constructs	O
will	O
ultimately	O
be	O
beneficial	O
in	O
innovation	O
towards	O
a	O
complete	O
osteochondral	O
scaffold	O
by	O
entrapping	O
hydroxyapatite	O
in	O
proximity	O
to	O
chondrocytes	O
and	O
hence	O
potentiating	O
the	O
development	O
of	O
a	O
ZCC	O
.	O

2	O
.	O

Experimental	O
Section	O

Gelatin	O
(	O
G2500	O
;	O
~	O
300	O
g	O
bloom	O
),	O
and	O
methacrylic	O
anhydride	O
(	O
MAAh	O
,	O
276685	O
)	O
were	O
purchased	O
from	O
Sigma	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
,	O
USA	O
).	O

Hyaluronic	O
acid	O
(	O
HA	O
;	O
molecular	O
weight	O
(	O
MW	O
)	O
0	O
.	O
86	O
MDa	O
)	O
was	O
purchased	O
from	O
Novozymes	O
.	O

2	O
-	O
hydroxy	O
-	O
1	O
-[	O
4	O
-(	O
2	O
-	O
hydroxyethoxy	O
)	O
phenyl	O
]-	O
2	O
-	O
methyl	O
-	O
1	O
-	O
propanone	O
(	O
Irgacure	O
2959	O
;	O
IC	O
)	O
was	O
purchased	O
from	O
BASF	O
(	O
BASF	O
,	O
Ludwigshafen	O
,	O
Germany	O
).	O

All	O
quoted	O
concentrations	O
in	O
percent	O
are	O
weight	O
per	O
volume	O
(%	O
w	O
/	O
v	O
)	O
unless	O
otherwise	O
noted	O
.	O

Alginate	O
(	O
9005	O
-	O
38	O
-	O
3	O
)	O
and	O
methyl	O
cellulose	O
(	O
9004	O
-	O
67	O
-	O
5	O
M0512	O
,	O
MW	O
88	O
kDa	O
)	O
were	O
purchased	O
from	O
Sigma	O
(	O
Sigma	O
-	O
Aldrich	O
,	O
Steinheim	O
,	O
Germany	O
)	O
and	O
hydroxyapatite	O
(	O
1	O
.	O
02196	O
.	O
1000	O
)	O
was	O
purchased	O
from	O
Merck	O
(	O
Darmstadt	O
,	O
Germany	O
).	O

Hydroxyapatite	O
particle	O
size	O
was	O
previously	O
quantified	O
using	O
Transmission	O
Electron	O
Microscopy	O
(	O
TEM	O
;	O
F30	O
,	O
FEI	O
,	O
Zürich	O
,	O
Switzerland	O
,	O
operated	O
at	O
200	O
kV	O
),	O
and	O
found	O
to	O
comprise	O
needle	O
-	O
shaped	O
particles	O
with	O
a	O
length	O
of	O
50	O
±	O
4	O
nm	O
and	O
width	O
of	O
17	O
±	O
2	O
nm	O
[	O
17	O
].	O

Calcium	O
chloride	O
dihydrate	O
(	O
10035	O
-	O
04	O
-	O
8	O
)	O
was	O
purchased	O
from	O
Roth	O
(	O
Karlsruhe	O
,	O
Germany	O
).	O

2	O
.	O
1	O
.	O

Polymer	O
Functionalization	O

Functionalization	O
of	O
gelatin	O
(	O
to	O
gelatin	O
methacrylamide	O
,	O
GelMA	O
)	O
and	O
HA	O
(	O
to	O
hyaluronic	O
acid	O
methacrylate	O
,	O
HAMA	O
),	O
was	O
performed	O
as	O
previously	O
described	O
[	O
18	O
,	O
19	O
].	O

Briefly	O
,	O
gelatin	O
and	O
HA	O
were	O
dissolved	O
in	O
Milli	O
-	O
Q	O
water	O
(	O
Merck	O
Millipore	O
,	O
Billerica	O
,	O
MA	O
,	O
USA	O
)	O
at	O
10	O
%	O
and	O
1	O
%,	O
respectively	O
.	O

In	O
the	O
case	O
of	O
gelatin	O
,	O
0	O
.	O
6	O
g	O
of	O
MAAh	O
per	O
1	O
g	O
was	O
added	O
and	O
reacted	O
for	O
1	O
h	O
at	O
50	O
°	O
C	O
[	O
18	O
].	O

HA	O
was	O
reacted	O
with	O
a	O
5	O
-	O
fold	O
molar	O
excess	O
of	O
MAAh	O
to	O
hydroxyl	O
groups	O
for	O
8	O
h	O
on	O
ice	O
,	O
with	O
pH	O
monitored	O
and	O
adjusted	O
to	O
8	O
with	O
5	O
M	O
NaOH	O
[	O
19	O
].	O

After	O
reaction	O
,	O
all	O
gel	O
solutions	O
were	O
subject	O
to	O
centrifugation	O
to	O
phase	O
separate	O
and	O
allow	O
the	O
removal	O
of	O
insoluble	O
MAAh	O
.	O

HAMA	O
was	O
precipitated	O
with	O
ice	O
-	O
cold	O
100	O
%	O
ethanol	O
and	O
collected	O
,	O
after	O
which	O
both	O
were	O
separately	O
dialyzed	O
against	O
Milli	O
-	O
Q	O
water	O
to	O
allow	O
the	O
diffusion	O
of	O
any	O
remainder	O
of	O
MAAh	O
or	O
methacrylic	O
acid	O
.	O

After	O
dialysis	O
,	O
GelMA	O
was	O
filtered	O
through	O
0	O
.	O
2	O
µm	O
filters	O
(	O
Merck	O
Millipore	O
)	O
under	O
aseptic	O
conditions	O
,	O
pH	O
adjusted	O
to	O
7	O
.	O
4	O
,	O
lyophilized	O
with	O
0	O
.	O
2	O
µm	O
filters	O
exclusively	O
providing	O
air	O
exchange	O
then	O
stored	O
at	O
−	O
20	O
°	O
C	O
in	O
sealed	O
,	O
sterile	O
tubes	O
.	O

HAMA	O
was	O
subject	O
to	O
the	O
same	O
processing	O
apart	O
from	O
initial	O
filtration	O
to	O
avoid	O
macromer	O
loss	O
due	O
to	O
the	O
large	O
molecular	O
weight	O
.	O

2	O
.	O
2	O
.	O

Degree	O
of	O
Functionalization	O

The	O
degree	O
of	O
functionalization	O
(	O
DOF	O
)	O
of	O
GelMA	O
and	O
HAMA	O
was	O
assessed	O
using	O
proton	O
nuclear	O
magnetic	O
resonance	O
(	O
1H	O
NMR	O
)	O
spectroscopy	O
.	O

A	O
Varian	O
Direct	O
Drive	O
NMR	O
spectrometer	O
(	O
Agilent	O
Technologies	O
,	O
Santa	O
Clara	O
,	O
CA	O
,	O
USA	O
)	O
operating	O
at	O
400	O
MHz	O
for	O
hydrogen	O
,	O
was	O
used	O
to	O
record	O
1H	O
NMR	O
spectra	O
.	O

All	O
samples	O
were	O
dissolved	O
at	O
1	O
.	O
0	O
%	O
in	O
D2O	O
at	O
a	O
temperature	O
of	O
50	O
°	O
C	O
.	O

Spectra	O
were	O
recorded	O
at	O
an	O
operational	O
temperature	O
of	O
50	O
°	O
C	O
,	O
with	O
32	O
scans	O
and	O
a	O
recycle	O
delay	O
of	O
30	O
s	O
.	O

For	O
GelMA	O
,	O
methacrylamide	O
shifts	O
were	O
normalized	O
against	O
the	O
aromatic	O
signal	O
of	O
phenylalanine	O
,	O
at	O
δ	O
7	O
.	O
4	O
ppm	O
[	O
20	O
].	O

DOF	O
was	O
defined	O
as	O
the	O
proportion	O
of	O
modified	O
lysine	O
groups	O
of	O
gelatin	O
,	O
as	O
previously	O
described	O
for	O
collagen	B-GP
I	I-GP
methacrylamide	O
[	O
20	O
].	O

The	O
area	O
obtained	O
from	O
the	O
integral	O
of	O
intensities	O
of	O
the	O
protons	O
present	O
at	O
the	O
methacrylamide	O
carbon	O
-	O
carbon	O
double	O
bond	O
(	O
IDB	O
)	O
occurring	O
at	O
δ	O
5	O
.	O
6	O
and	O
5	O
.	O
8	O
ppm	O
was	O
normalized	O
to	O
proton	O
number	O
(	O
nHDB	O
),	O
and	O
the	O
area	O
obtained	O
from	O
integrating	O
the	O
peak	O
of	O
the	O
aromatic	O
groups	O
(	O
IA	O
)	O
was	O
normalized	O
to	O
the	O
protons	O
interacting	O
with	O
the	O
aromatic	O
ring	O
(	O
nHA	O
).	O

The	O
prevalence	O
of	O
modified	O
groups	O
and	O
aromatic	O
residues	O
were	O
then	O
normalized	O
to	O
their	O
prevalence	O
by	O
number	O
in	O
porcine	O
gelatin	O
in	O
order	O
to	O
allow	O
for	O
the	O
quantitation	O
of	O
total	O
methacrylamide	O
to	O
total	O
possible	O
lysine	O
groups	O
(	O
Equation	O
(	O
1	O
))	O
[	O
21	O
]:	O
(	O
1	O
)	O
DOFGelMA	O
(%)=	O
(	O
IDBnHDB	O
)/%	O
Lys	O
(	O
IAnHA	O
)/%	O
Phe	O

For	O
HAMA	O
,	O
chemical	O
shifts	O
were	O
normalized	O
against	O
the	O
signal	O
from	O
the	O
n	O
-	O
acetyl	O
group	O
on	O
the	O
HA	O
backbone	O
at	O
δ	O
2	O
.	O
1	O
ppm	O
[	O
22	O
].	O

The	O
DOF	O
,	O
which	O
in	O
this	O
case	O
was	O
defined	O
as	O
the	O
fraction	O
of	O
modified	O
hydroxyl	O
groups	O
per	O
repeating	O
unit	O
,	O
was	O
determined	O
as	O
previously	O
described	O
[	O
22	O
].	O

In	O
brief	O
,	O
the	O
average	O
area	O
found	O
from	O
integrating	O
the	O
proton	O
peak	O
at	O
the	O
double	O
bond	O
(~	O
δ	O
5	O
.	O
8	O
and	O
6	O
.	O
3	O
ppm	O
;	O
IDB	O
)	O
was	O
normalized	O
to	O
the	O
number	O
of	O
protons	O
at	O
the	O
double	O
bond	O
(	O
nHDB	O
)	O
and	O
the	O
area	O
found	O
from	O
integrating	O
the	O
proton	O
peak	O
of	O
the	O
n	O
-	O
acetyl	O
group	O
(	O
ICH3	O
)	O
was	O
normalized	O
to	O
the	O
number	O
of	O
protons	O
in	O
the	O
n	O
-	O
acetyl	O
group	O
(	O
nHCH3R	O
);	O
the	O
normalized	O
double	O
bond	O
value	O
was	O
then	O
divided	O
by	O
the	O
normalized	O
n	O
-	O
acetyl	O
group	O
value	O
to	O
give	O
the	O
number	O
of	O
functional	O
groups	O
,	O
which	O
was	O
assessed	O
as	O
a	O
fraction	O
of	O
nOHM	O
,	O
the	O
total	O
number	O
of	O
target	O
reactive	O
hydroxyl	O
groups	O
(	O
4	O
)	O
present	O
in	O
a	O
repeating	O
monomer	O
unit	O
of	O
HA	O
,	O
finally	O
resulting	O
in	O
the	O
percentage	O
of	O
DOF	O
,	O
as	O
illustrated	O
below	O
(	O
Equation	O
(	O
2	O
)):	O
(	O
2	O
)	O
DOFHAMA	O
(%)=	O
IDBnHDB	O
/	O
ICH3RnHCH3RnOHM	O
×	O
100	O

2	O
.	O
3	O
.	O

Hydroxyapatite	O
/	O
Alginate	O
Scaffold	O
Plotting	O

Pastes	O
were	O
made	O
containing	O
42	O
%	O
(	O
wt	O
/	O
wt	O
)	O
HAP	O
,	O
1	O
.	O
74	O
%	O
(	O
wt	O
/	O
wt	O
)	O
alginate	O
and	O
Milli	O
-	O
Q	O
H2O	O
(	O
for	O
ALG	O
/	O
HAP	O
scaffolds	O
),	O
and	O
10	O
%	O
(	O
wt	O
/	O
wt	O
)	O
methyl	O
cellulose	O
,	O
1	O
.	O
74	O
%	O
(	O
wt	O
/	O
wt	O
)	O
alginate	O
and	O
Milli	O
-	O
Q	O
H2O	O
(	O
for	O
pure	O
alginate	O
(	O
ALG	O
)	O
control	O
scaffolds	O
).	O

An	O
iterative	O
process	O
was	O
used	O
for	O
the	O
development	O
of	O
the	O
final	O
paste	O
composition	O
,	O
with	O
the	O
above	O
blend	O
of	O
alginate	O
and	O
methyl	O
cellulose	O
providing	O
highest	O
fidelity	O
and	O
structural	O
integrity	O
.	O

Pastes	O
were	O
3D	O
plotted	O
in	O
air	O
using	O
a	O
BioScaffolder	O
2	O
.	O
1	O
(	O
GeSiM	O
,	O
Großerkmannsdorf	O
,	O
Germany	O
)	O
into	O
a	O
4	O
×	O
4	O
×	O
~	O
0	O
.	O
5	O
mm	O
grid	O
using	O
a	O
410	O
µm	O
(	O
inner	O
diameter	O
)	O
needle	O
,	O
with	O
a	O
printing	O
speed	O
of	O
3	O
mm	O
·	O
s	O
−	O
1	O
.	O

Extrusion	O
pressure	O
of	O
380	O
kPa	O
and	O
250	O
kPa	O
were	O
used	O
for	O
ALG	O
/	O
HAP	O
and	O
pure	O
ALG	O
scaffolds	O
,	O
respectively	O
.	O

A	O
start	O
-	O
break	O
(	O
the	O
application	O
of	O
pressure	O
in	O
advance	O
of	O
the	O
printing	O
of	O
a	O
strand	O
,	O
i	O
.	O
e	O
.,	O
during	O
the	O
approach	O
of	O
the	O
nozzle	O
to	O
the	O
designated	O
start	O
point	O
)	O
of	O
0	O
.	O
5	O
s	O
was	O
used	O
to	O
ensure	O
the	O
initial	O
region	O
of	O
each	O
strand	O
was	O
printed	O
with	O
a	O
stabilized	O
flow	O
.	O

Further	O
information	O
regarding	O
printing	O
parameters	O
may	O
be	O
found	O
in	O
Kumar	O
et	O
al	O
.	O
[	O
17	O
].	O

Scaffold	O
design	O
consisted	O
of	O
2	O
printed	O
layers	O
with	O
4	O
strands	O
per	O
layer	O
.	O

After	O
plotting	O
,	O
scaffolds	O
were	O
stored	O
in	O
1	O
m	O
CaCl2	O
solution	O
at	O
4	O
°	O
C	O
until	O
the	O
day	O
of	O
cell	O
encapsulation	O
.	O

2	O
.	O
4	O
.	O

Micro	O
-	O
Computed	O
Tomography	O
Imaging	O

Micro	O
-	O
Computed	O
Tomography	O
(	O
µCT	O
)	O
was	O
used	O
to	O
qualitatively	O
assess	O
constructs	O
containing	O
ALG	O
and	O
HAP	O
(	O
Scanco	O
Medical	O
µCT	O
40	O
,	O
operated	O
at	O
55	O
kVp	O
and	O
145	O
µA	O
;	O
Scanco	O
Medical	O
,	O
Brüttisellen	O
,	O
Switzerland	O
),	O
and	O
determine	O
HAP	O
localization	O
within	O
the	O
constructs	O
.	O

2	O
.	O
5	O
.	O

Cell	O
Isolation	O
and	O
Expansion	O

The	O
full	O
procedure	O
for	O
isolating	O
chondrocytes	O
is	O
described	O
elsewhere	O
[	O
23	O
].	O

In	O
brief	O
,	O
cartilage	O
samples	O
were	O
removed	O
from	O
macroscopically	O
normal	O
regions	O
of	O
the	O
femoral	O
condyle	O
of	O
a	O
patient	O
undergoing	O
full	O
knee	O
replacement	O
surgery	O
,	O
with	O
patient	O
consent	O
and	O
ethical	O
approval	O
from	O
the	O
Prince	O
Charles	O
Hospital	O
and	O
Queensland	O
University	O
of	O
Technology	O
(	O
Ethics	O
RM	O
:	O
1400001024	O
).	O

After	O
excision	O
,	O
chondrocytes	O
were	O
cultured	O
and	O
expanded	O
in	O
low	O
-	O
glucose	O
DMEM	O
with	O
10	O
%	O
fetal	O
bovine	O
serum	O
(	O
Lonza	O
,	O
Waverly	O
,	O
Australia	O
),	O
2	O
mM	O
glutamax	O
,	O
10	O
mM	O
4	O
-(	O
2	O
-	O
hydroxyethyl	O
)-	O
1	O
-	O
piperazineethanesulfonic	O
acid	O
(	O
HEPES	O
),	O
0	O
.	O
1	O
mM	O
non	O
-	O
essential	O
amino	O
acids	O
(	O
NEAAs	O
),	O
0	O
.	O
5	O
µg	O
·	O
mL	O
−	O
1	O
amphotericin	O
B	O
(	O
Fungizone	O
®;	O
Thermo	O
Fisher	O
Scientific	O
,	O
Waltham	O
,	O
MA	O
,	O
USA	O
),	O
50	O
U	O
·	O
mL	O
−	O
1	O
penicillin	O
G	O
sodium	O
,	O
50	O
µg	O
·	O
mL	O
−	O
1	O
streptomycin	O
(	O
all	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
,	O
Waltham	O
,	O
MA	O
,	O
USA	O
),	O
0	O
.	O
4	O
mM	O
l	O
-	O
proline	O
and	O
0	O
.	O
1	O
mM	O
ascorbic	O
acid	O
(	O
Sigma	O
)	O
and	O
used	O
at	O
passage	O
3	O
.	O

2	O
.	O
6	O
.	O

Hydrogel	O
Formation	O
and	O
Culture	O

Stock	O
solutions	O
of	O
GelMA	O
,	O
HAMA	O
and	O
IC	O
were	O
made	O
in	O
PBS	O
on	O
the	O
day	O
of	O
gel	O
formation	O
.	O

Groups	O
consisted	O
of	O
(	O
Figure	O
1	O
):	O
10	O
%	O
GelMA	O
/	O
ALG	O
control	O
scaffold	O
(	O
GelMA	O
-	O
ALG	O
);	O
10	O
%	O
GelMA	O
/	O
0	O
.	O
5	O
%	O
HAMA	O
/	O
ALG	O
control	O
scaffold	O
(	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
);	O
10	O
%	O
GelMA	O
/	O
HAP	O
scaffold	O
(	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
);	O
and	O
10	O
%	O
GelMA	O
/	O
0	O
.	O
5	O
%	O
HAMA	O
/	O
HAP	O
scaffold	O
(	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
).	O

ALG	O
and	O
ALG	O
/	O
HAP	O
3D	O
plotted	O
scaffolds	O
were	O
placed	O
into	O
custom	O
Teflon	O
molds	O
(	O
50	O
×	O
4	O
×	O
2	O
mm	O
strips	O
)	O
and	O
rinsed	O
twice	O
with	O
DMEM	O
to	O
reduce	O
calcium	O
content	O
from	O
storage	O
.	O

Hydrogel	O
precursor	O
solutions	O
containing	O
0	O
.	O
05	O
%	O
IC	O
were	O
equilibrated	O
at	O
37	O
°	O
C	O
for	O
15	O
min	O
in	O
an	O
incubator	O
.	O

Chondrocytes	O
at	O
a	O
density	O
of	O
106	O
mL	O
−	O
1	O
were	O
added	O
,	O
and	O
the	O
mixtures	O
were	O
pipetted	O
into	O
the	O
molds	O
over	O
the	O
scaffolds	O
and	O
covered	O
with	O
glass	O
slides	O
.	O

Storage	O
of	O
10	O
min	O
at	O
4	O
°	O
C	O
was	O
performed	O
to	O
allow	O
GelMA	O
to	O
physically	O
crosslink	O
,	O
equilibrate	O
groups	O
,	O
and	O
minimize	O
cell	O
settling	O
.	O

UV	O
crosslinking	O
was	O
done	O
using	O
365	O
nm	O
light	O
for	O
a	O
total	O
energy	O
of	O
1500	O
mJ	O
·	O
cm	O
−	O
2	O
(	O
2	O
.	O
3	O
mW	O
·	O
cm	O
−	O
2	O
for	O
11	O
min	O
)	O
in	O
a	O
CL	O
-	O
1000	O
L	O
crosslinker	O
(	O
UVP	O
,	O
Upland	O
,	O
CA	O
,	O
USA	O
).	O

Cell	O
-	O
free	O
groups	O
were	O
made	O
in	O
the	O
same	O
fashion	O
,	O
with	O
cellular	O
volume	O
accounted	O
for	O
in	O
dilutions	O
.	O

After	O
crosslinking	O
,	O
gel	O
strips	O
were	O
cut	O
to	O
4	O
×	O
4	O
×	O
2	O
mm	O
and	O
divided	O
into	O
48	O
-	O
well	O
plates	O
.	O

After	O
gels	O
were	O
divided	O
,	O
they	O
were	O
cultured	O
for	O
28	O
days	O
in	O
chondrogenic	O
differentiation	O
media	O
(	O
high	O
-	O
glucose	O
DMEM	O
with	O
2	O
mM	O
glutamax	O
,	O
10	O
mM	O
HEPES	O
,	O
0	O
.	O
1	O
mM	O
NEAAs	O
,	O
0	O
.	O
5	O
µg	O
·	O
mL	O
−	O
1	O
amphotericin	O
B	O
(	O
Fungizone	O
®;	O
Thermo	O
Fisher	O
Scientific	O
:	O
Waltham	O
,	O
MA	O
,	O
USA	O
),	O
50	O
U	O
·	O
mL	O
−	O
1	O
penicillin	O
G	O
sodium	O
,	O
50	O
µg	O
·	O
mL	O
−	O
1	O
streptomycin	O
,	O
ITS	O
-	O
G	O
(	O
100	O
×	O
dilution	O
;	O
all	O
Life	O
Technologies	O
),	O
1	O
.	O
25	O
mg	O
·	O
mL	O
−	O
1	O
bovine	O
serum	O
albumin	B-GP
(	O
BSA	B-GP
),	O
0	O
.	O
4	O
mM	O
l	O
-	O
proline	O
,	O
0	O
.	O
1	O
mM	O
ascorbic	O
acid	O
,	O
0	O
.	O
1	O
µM	O
dexamethasone	O
(	O
all	O
Sigma	O
)	O
and	O
10	O
ng	O
·	O
mL	O
−	O
1	O
transforming	B-GP
growth	I-GP
factor	I-GP
-	I-GP
β3	I-GP
(	O
TGF	B-GP
-	I-GP
β3	I-GP
;	O
GroPep	O
,	O
Adelaide	O
,	O
Australia	O
).	O

Media	O
was	O
changed	O
three	O
times	O
a	O
week	O
.	O

2	O
.	O
7	O
.	O

Viability	O
Assay	O

Viability	O
was	O
assessed	O
on	O
day	O
1	O
of	O
culture	O
(	O
n	O
=	O
3	O
samples	O
per	O
group	O
).	O

Gels	O
were	O
cut	O
in	O
half	O
and	O
thereafter	O
treated	O
with	O
fluorescein	O
diacetate	O
(	O
FDA	O
)	O
and	O
propidium	O
iodide	O
(	O
PrI	O
;	O
both	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
:	O
Waltham	O
,	O
MA	O
,	O
USA	O
)	O
to	O
stain	O
live	O
and	O
dead	O
cells	O
,	O
respectively	O
.	O

Gels	O
were	O
rinsed	O
twice	O
in	O
fresh	O
PBS	O
then	O
incubated	O
for	O
5	O
min	O
at	O
37	O
°	O
C	O
in	O
a	O
5	O
µg	O
·	O
mL	O
−	O
1	O
FDA	O
,	O
0	O
.	O
5	O
µg	O
·	O
mL	O
−	O
1	O
PrI	O
PBS	O
solution	O
.	O

Samples	O
were	O
imaged	O
across	O
the	O
cross	O
-	O
section	O
using	O
fluorescence	O
microscopy	O
(	O
Zeiss	O
Axio	O
Imager	O
M2	O
;	O
excitation	O
:	O
488	O
nm	O
and	O
568	O
nm	O
,	O
absorption	O
520	O
nm	O
and	O
640	O
nm	O
for	O
FDA	O
and	O
PrI	O
,	O
respectively	O
—	O
1	O
.	O
33	O
µm	O
·	O
pixel	O
−	O
1	O
).	O

Quantification	O
was	O
performed	O
using	O
ImageJ	O
software	O
(	O
National	O
Institutes	O
of	O
Health	O
,	O
New	O
York	O
,	O
NY	O
,	O
USA	O
).	O

As	O
chondrocytes	O
were	O
used	O
in	O
this	O
study	O
,	O
culture	O
plate	O
positive	O
and	O
negative	O
staining	O
controls	O
were	O
not	O
used	O
—	O
the	O
cells	O
would	O
be	O
unable	O
to	O
recover	O
a	O
rounded	O
morphology	O
in	O
this	O
setting	O
and	O
thus	O
provide	O
erroneous	O
control	O
data	O
.	O

2	O
.	O
8	O
.	O

Mechanical	O
Properties	O

Mechanical	O
testing	O
was	O
performed	O
on	O
days	O
1	O
and	O
28	O
on	O
cell	O
-	O
free	O
and	O
cell	O
-	O
containing	O
samples	O
using	O
an	O
Instron	O
MicroTester	O
(	O
Model	O
5848	O
;	O
Instron	O
,	O
Norwood	O
,	O
MA	O
,	O
USA	O
).	O

Each	O
sample	O
was	O
placed	O
in	O
a	O
37	O
°	O
C	O
PBS	O
trough	O
into	O
which	O
an	O
aluminum	O
plunger	O
was	O
submerged	O
for	O
unconfined	O
compressive	O
displacement	O
.	O

The	O
testing	O
regimen	O
consisted	O
of	O
a	O
preliminary	O
height	O
measurement	O
(	O
Δforce	O
(	O
F	O
)	O
=	O
−	O
0	O
.	O
01	O
N	O
as	O
height	O
criterion	O
),	O
followed	O
by	O
a	O
0	O
.	O
5	O
%	O
strain	O
(	O
ε	O
)/	O
s	O
(	O
s	O
)	O
ramp	O
to	O
16	O
%	O
ε	O
for	O
compressive	O
elastic	O
modulus	O
measurement	O
.	O

The	O
value	O
for	O
elastic	O
modulus	O
was	O
derived	O
from	O
the	O
slope	O
of	O
the	O
stress	O
-	O
strain	O
curve	O
from	O
10	O
%	O
to	O
15	O
%	O
strain	O
.	O

2	O
.	O
9	O
.	O

Biochemical	O
Assays	O

Gels	O
harvested	O
on	O
days	O
1	O
and	O
28	O
were	O
disrupted	O
by	O
passing	O
through	O
a	O
19	O
G	O
needle	O
and	O
digested	O
in	O
0	O
.	O
5	O
mg	O
·	O
mL	O
−	O
1	O
Proteinase	B-GP
K	I-GP
solution	O
,	O
on	O
a	O
shaker	O
plate	O
overnight	O
at	O
56	O
°	O
C	O
.	O

The	O
DNA	O
content	O
was	O
quantified	O
using	O
the	O
Quant	O
-	O
iT	O
™	O
PicoGreen	O
®	O
dsDNA	O
assay	O
kit	O
(	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
:	O
Waltham	O
,	O
MA	O
,	O
USA	O
)	O
according	O
to	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

GAG	O
content	O
of	O
proteinase	B-GP
K	I-GP
-	O
digested	O
hydrogel	O
and	O
culture	O
media	O
samples	O
were	O
assessed	O
using	O
the	O
dimethyl	O
-	O
methylene	O
blue	O
(	O
DMMB	O
)	O
assay	O
(	O
pH	O
1	O
.	O
5	O
)	O
(	O
sample	O
GAG	O
on	O
days	O
1	O
and	O
28	O
,	O
media	O
on	O
days	O
14	O
and	O
28	O
).	O

Absorbances	O
at	O
525	O
and	O
590	O
nm	O
were	O
taken	O
,	O
with	O
the	O
ratio	O
of	O
the	O
two	O
absorbances	O
normalized	O
to	O
a	O
chondroitin	O
sulfate	O
C	O
(	O
Sigma	O
)	O
standard	O
to	O
give	O
the	O
GAG	O
content	O
.	O

All	O
GAG	O
content	O
measurements	O
were	O
normalized	O
using	O
cell	O
-	O
free	O
constructs	O
to	O
account	O
for	O
GAGs	O
released	O
from	O
the	O
hydrogels	O
versus	O
GAGs	O
produced	O
by	O
the	O
cells	O
.	O

2	O
.	O
10	O
.	O

Gene	O
Expression	O

RNA	O
was	O
extracted	O
from	O
constructs	O
cultured	O
for	O
28	O
days	O
;	O
gels	O
were	O
frozen	O
at	O
−	O
80	O
°	O
C	O
in	O
1	O
mL	O
of	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
:	O
Waltham	O
,	O
MA	O
,	O
USA	O
),	O
and	O
RNA	O
was	O
extracted	O
according	O
to	O
manufacturer	O
’	O
s	O
instructions	O
.	O

SuperScript	O
™	O
III	O
First	O
Strand	O
Synthesis	O
System	O
(	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
,	O
Waltham	O
,	O
MA	O
,	O
USA	O
)	O
was	O
used	O
to	O
synthesize	O
complementary	O
DNA	O
(	O
cDNA	O
).	O

DNase	B-GP
digestion	O
was	O
performed	O
prior	O
to	O
cDNA	O
synthesis	O
and	O
RNase	B-GP
digestion	O
was	O
performed	O
after	O
.	O

Primer	O
sequences	O
were	O
either	O
obtained	O
from	O
the	O
literature	O
for	O
RPL13A	B-GP
,	O
COL1A1	B-GP
,	O
COL2A1	B-GP
,	O
ACAN	B-GP
and	O
COL10A1	B-GP
[	O
9	O
,	O
24	O
]	O
or	O
designed	O
using	O
Primer	O
-	O
BLAST	O
(	O
NCBI	O
,	O
Bethesda	O
,	O
MD	O
)	O
for	O
TBP	B-GP
(	O
5	O
′→	O
3	O
′	O
F	O
:	O
AGCCAAGAGTGAAGAACAGTC	O
,	O
R	O
:	O
CATCACAGCTCCCCACCATATT	O
).	O

Real	O
-	O
time	O
quantitative	O
reverse	B-GP
transcriptase	I-GP
polymerase	B-GP
chain	O
reactions	O
(	O
PCR	O
)	O
were	O
performed	O
in	O
duplicates	O
in	O
a	O
7500	O
PCR	O
system	O
(	O
Applied	O
Biosystems	O
,	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
)	O
using	O
SybrGreen	O
Mastermix	O
(	O
Applied	O
Biosystems	O
/	O
Invitrogen	O
;	O
Thermo	O
Fisher	O
Scientific	O
:	O
Waltham	O
,	O
MA	O
,	O
USA	O
).	O

The	O
cycle	O
threshold	O
(	O
Ct	O
)	O
value	O
of	O
each	O
gene	O
was	O
normalized	O
to	O
the	O
geometric	O
mean	O
of	O
the	O
housekeeping	B-GP
genes	I-GP
RPL13A	B-GP
and	O
TBP	B-GP
using	O
the	O
comparative	O
Ct	O
method	O
(	O
2	O
−∆	O
Ct	O
).	O

2	O
.	O
11	O
.	O

Immunofluorescence	O

Gels	O
from	O
day	O
28	O
were	O
frozen	O
in	O
Optimal	O
Cutting	O
Temperature	O
compound	O
(	O
OCT	O
,	O
Sakura	O
,	O
Finetek	O
,	O
Tokyo	O
,	O
Japan	O
)	O
and	O
sectioned	O
on	O
a	O
cryo	O
-	O
microtome	O
at	O
−	O
20	O
°	O
C	O
.	O

Sections	O
were	O
fixed	O
with	O
ice	O
-	O
cold	O
acetone	O
for	O
15	O
min	O
,	O
followed	O
by	O
antigen	O
retrieval	O
with	O
0	O
.	O
1	O
%	O
hyaluronidase	B-GP
(	O
Sigma	O
)	O
for	O
30	O
min	O
,	O
which	O
was	O
only	O
included	O
in	O
the	O
collagen	B-GP
I	I-GP
and	O
II	O
staining	O
procedures	O
.	O

Primary	O
antibodies	B-GP
were	O
diluted	O
in	O
2	O
%	O
goat	B-OG
serum	O
in	O
PBS	O
(	O
Jackson	O
ImmunoResearch	O
,	O
West	O
Grove	O
,	O
PA	O
,	O
USA	O
),	O
and	O
applied	O
overnight	O
at	O
4	O
°	O
C	O
in	O
a	O
moist	O
chamber	O
.	O

Antibodies	B-GP
for	O
collagen	B-GP
type	I-GP
I	I-GP
(	O
I	O
-	O
8H5	O
,	O
MP	O
Biomedicals	O
,	O
Seven	O
Hills	O
,	O
Australia	O
,	O
1	O
:	O
300	O
dilution	O
),	O
collagen	B-GP
type	I-GP
II	I-GP
(	O
II	O
-	O
II6B3	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
(	O
DSHB	O
),	O
Iowa	O
City	O
,	O
IA	O
,	O
USA	O
,	O
1	O
:	O
200	O
dilution	O
),	O
collagen	B-GP
type	I-GP
X	I-GP
(	O
14	O
-	O
9771	O
-	O
82	O
Clone	O
X53	O
,	O
Jomar	O
Bioscience	O
Pty	O
Ltd	O
.,	O
Kensington	O
,	O
Australia	O
,	O
1	O
:	O
300	O
dilution	O
),	O
aggrecan	B-GP
(	O
969D4D11	O
,	O
Life	O
Technologies	O
1	O
:	O
300	O
dilution	O
)	O
or	O
isotype	O
controls	O
(	O
mouse	B-OG
IgG	B-GP
,	O
Jackson	O
,	O
1	O
:	O
1000	O
)	O
were	O
used	O
.	O

Subsequently	O
,	O
sections	O
were	O
incubated	O
in	O
2	O
%	O
donkey	B-OG
serum	O
/	O
PBS	O
with	O
IgG1	B-GP
-	O
specific	O
AlexaFluor	O
®	O
488	O
-	O
labelled	O
goat	B-OG
anti	O
-	O
mouse	B-OG
secondary	O
antibodies	B-GP
and	O
IgG2a	B-GP
-	O
specific	O
AlexaFluor	O
®	O
594	O
-	O
labelled	O
goat	B-OG
anti	O
-	O
mouse	B-OG
secondary	O
antibodies	B-GP
(	O
Jackson	O
1	O
:	O
150	O
)	O
and	O
5	O
µg	O
·	O
mL	O
−	O
1	O
4	O
′,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
(	O
DAPI	O
,	O
Sigma	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

Images	O
were	O
captured	O
with	O
fixed	O
exposure	O
times	O
on	O
a	O
Zeiss	O
Axio	O
Imager	O
M2	O
microscope	O
with	O
epi	O
-	O
fluorescence	O
attachment	O
(	O
Carl	O
Zeiss	O
,	O
Jena	O
,	O
Germany	O
).	O

2	O
.	O
12	O
.	O

Statistical	O
Analyses	O

Analysis	O
of	O
Variance	O
(	O
ANOVA	O
)	O
tests	O
were	O
used	O
to	O
assess	O
differences	O
between	O
groups	O
,	O
with	O
Tukey	O
’	O
s	O
post	O
-	O
hoc	O
tests	O
used	O
to	O
determine	O
inter	O
-	O
type	O
relationships	O
in	O
groups	O
with	O
equal	O
variances	O
assumed	O
(	O
e	O
.	O
g	O
.,	O
cell	O
-	O
free	O
constructs	O
);	O
Dunnet	O
’	O
s	O
T3	O
post	O
-	O
hoc	O
test	O
was	O
used	O
for	O
cell	O
-	O
containing	O
samples	O
,	O
assuming	O
unequal	O
variances	O
.	O

Tests	O
were	O
conducted	O
using	O
SPSS	O
21	O
.	O
0	O
(	O
IBM	O
Corporation	O
:	O
Armonk	O
,	O
NY	O
,	O
USA	O
)	O
with	O
p	O
-	O
values	O
<	O
0	O
.	O
05	O
regarded	O
as	O
significant	O
.	O

Figure	O
bars	O
show	O
mean	O
±	O
standard	O
deviation	O
.	O

Captions	O
state	O
where	O
independent	O
sample	O
t	O
-	O
tests	O
were	O
used	O
instead	O
of	O
ANOVA	O
.	O

Statistically	O
significant	O
differences	O
are	O
indicated	O
using	O
Roman	O
numerals	O
or	O
symbols	O
;	O
any	O
groups	O
sharing	O
a	O
Roman	O
numeral	O
are	O
statistically	O
similar	O
whilst	O
groups	O
without	O
a	O
like	O
numeral	O
are	O
different	O
.	O

3	O
.	O

Results	O

3	O
.	O
1	O
.	O

Scaffold	O
Manufacturing	O
by	O
3D	O
Plotting	O

Scaffolds	O
were	O
successfully	O
fabricated	O
using	O
the	O
BioScaffolder	O
2	O
.	O
1	O
and	O
remained	O
intact	O
from	O
day	O
1	O
(	O
Figure	O
2A	O
)	O
to	O
day	O
28	O
of	O
culture	O
(	O
Figure	O
2B	O
).	O

Visualization	O
of	O
scaffolds	O
in	O
combination	O
with	O
gels	O
was	O
done	O
using	O
µCT	O
and	O
confirmed	O
localization	O
of	O
hydroxyapatite	O
to	O
the	O
deep	O
region	O
of	O
the	O
construct	O
(	O
GelMA	O
-	O
ALG	O
Figure	O
2C	O
,	O
GelMA	O
-	O
HAP	O
Figure	O
2D	O
).	O

Four	O
groups	O
were	O
chosen	O
for	O
the	O
study	O
(	O
Figure	O
1	O
),	O
comprising	O
HAP	O
-	O
containing	O
(	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
,	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
)	O
and	O
HAP	O
-	O
free	O
(	O
GelMA	O
-	O
ALG	O
,	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
)	O
constructs	O
.	O

3	O
.	O
2	O
.	O

Degree	O
of	O
Functionalization	O

To	O
form	O
photocrosslinkable	O
polymers	O
,	O
gelatin	O
and	O
hyaluronic	O
acid	O
were	O
functionalized	O
using	O
varied	O
molar	O
excesses	O
of	O
MAAh	O
.	O
1H	O
NMR	O
analysis	O
was	O
performed	O
to	O
obtain	O
DOF	O
from	O
NMR	O
spectra	O
(	O
Figure	O
3	O
).	O

GelMA	O
was	O
found	O
to	O
be	O
76	O
.	O
2	O
%	O
functionalized	O
,	O
and	O
HAMA	O
was	O
25	O
.	O
0	O
%.	O

3	O
.	O
3	O
.	O

Viability	O

Live	O
/	O
dead	O
staining	O
was	O
performed	O
using	O
FDA	O
(	O
live	O
)	O
and	O
PrI	O
(	O
dead	O
)	O
to	O
assess	O
cytotoxicity	O
of	O
the	O
scaffolds	O
or	O
the	O
hydrogel	O
system	O
.	O

No	O
abnormal	O
cytotoxic	O
effects	O
were	O
detected	O
from	O
scaffolds	O
on	O
day	O
1	O
of	O
culture	O
in	O
any	O
group	O
(	O
Figure	O
4A	O
–	O
D	O
),	O
with	O
no	O
significant	O
difference	O
between	O
quantified	O
scaffold	O
viability	O
(	O
Figure	O
4E	O
;	O
n	O
=	O
3	O
samples	O
per	O
group	O
).	O

A	O
viability	O
of	O
80	O
%	O
is	O
an	O
expected	O
value	O
considering	O
chondrocyte	O
expansion	O
,	O
encapsulation	O
and	O
processing	O
through	O
UV	O
radical	O
polymerization	O
.	O

3	O
.	O
4	O
.	O

Mechanical	O
Properties	O

Mechanical	O
testing	O
was	O
performed	O
on	O
cell	O
-	O
free	O
and	O
cell	O
-	O
containing	O
(	O
human	B-OG
articular	O
chondrocytes	O
,	O
HAC	O
)	O
constructs	O
to	O
assess	O
purely	O
material	O
-	O
based	O
stiffness	O
as	O
well	O
as	O
stiffness	O
due	O
to	O
ECM	O
deposition	O
throughout	O
culture	O
.	O

Elastic	O
modulus	O
was	O
found	O
to	O
be	O
slightly	O
higher	O
in	O
cell	O
-	O
free	O
HAP	O
groups	O
(	O
Figure	O
5A	O
;	O
n	O
=	O
3	O
per	O
group	O
),	O
with	O
significant	O
difference	O
only	O
observed	O
between	O
GelMA	O
-	O
ALG	O
,	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
and	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
on	O
day	O
1	O
.	O

On	O
day	O
28	O
,	O
difference	O
was	O
noted	O
between	O
GelMA	O
-	O
ALG	O
and	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
.	O

Modulus	O
of	O
cell	O
-	O
free	O
constructs	O
did	O
not	O
increase	O
during	O
culture	O
,	O
which	O
ensured	O
changes	O
in	O
cell	O
-	O
containing	O
gels	O
were	O
cell	O
-	O
mediated	O
.	O

Cell	O
-	O
containing	O
gels	O
(	O
Figure	O
5B	O
;	O
n	O
=	O
3	O
per	O
group	O
)	O
were	O
not	O
significantly	O
different	O
on	O
day	O
1	O
,	O
but	O
all	O
significantly	O
increased	O
over	O
the	O
culture	O
period	O
.	O

It	O
was	O
found	O
that	O
GelMA	O
-	O
ALG	O
(~	O
50	O
kPa	O
)	O
was	O
significantly	O
lower	O
than	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
(~	O
65	O
kPa	O
),	O
with	O
the	O
two	O
HAP	O
groups	O
significantly	O
higher	O
than	O
the	O
ALG	O
control	O
groups	O
but	O
statistically	O
similar	O
to	O
each	O
other	O
(	O
GelMA	O
/	O
ALG	O
-	O
HAP	O
:	O
~	O
77	O
kPa	O
,	O
GelMA	O
-	O
HAMA	O
/	O
ALG	O
-	O
HAP	O
:	O
~	O
85	O
kPa	O
).	O

3	O
.	O
5	O
.	O

DNA	O
and	O
GAG	O
Content	O

Measurements	O
of	O
DNA	O
content	O
and	O
GAG	O
content	O
were	O
performed	O
on	O
all	O
construct	O
groups	O
,	O
with	O
GAG	O
content	O
in	O
media	O
also	O
measured	O
.	O

In	O
all	O
cases	O
cell	O
-	O
free	O
constructs	O
were	O
used	O
to	O
correct	O
for	O
any	O
material	O
-	O
based	O
content	O
potentially	O
interfering	O
with	O
the	O
GAG	O
measurements	O
.	O

These	O
data	O
were	O
collected	O
to	O
illustrate	O
whether	O
there	O
were	O
proliferative	O
differences	O
between	O
groups	O
(	O
DNA	O
content	O
),	O
and	O
to	O
assess	O
chondrogenesis	O
(	O
GAG	O
content	O
).	O

Normalization	O
of	O
GAG	O
content	O
to	O
DNA	O
content	O
was	O
done	O
to	O
account	O
for	O
cell	O
number	O
skewing	O
raw	O
GAG	O
content	O
per	O
wet	O
weight	O
data	O
.	O

Large	O
increases	O
in	O
GAG	O
content	O
per	O
wet	O
weight	O
were	O
observed	O
between	O
days	O
1	O
and	O
28	O
,	O
with	O
all	O
groups	O
increasing	O
from	O
between	O
5	O
-	O
and	O
8	O
-	O
fold	O
(	O
Figure	O
6A	O
).	O

GAG	O
content	O
per	O
wet	O
weight	O
in	O
the	O
GelMA	O
-	O
ALG	O
and	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
groups	O
were	O
significantly	O
different	O
to	O
the	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
and	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
groups	O
,	O
however	O
no	O
differences	O
were	O
found	O
between	O
ALG	O
and	O
ALG	O
/	O
HAP	O
within	O
each	O
gel	O
blend	O
.	O

Overall	O
,	O
HAMA	O
appeared	O
to	O
have	O
a	O
positive	O
effect	O
on	O
chondrogenesis	O
during	O
culture	O
.	O

The	O
DNA	O
content	O
in	O
constructs	O
increased	O
slightly	O
over	O
the	O
culture	O
period	O
,	O
which	O
showed	O
that	O
cellular	O
activity	O
was	O
maintained	O
(	O
Figure	O
6B	O
).	O

GAG	O
content	O
per	O
DNA	O
content	O
data	O
shared	O
the	O
same	O
trends	O
as	O
GAG	O
content	O
per	O
wet	O
weight	O
,	O
as	O
would	O
be	O
expected	O
with	O
stable	O
DNA	O
levels	O
throughout	O
the	O
culture	O
and	O
between	O
groups	O
(	O
Figure	O
6C	O
).	O

GAG	O
content	O
per	O
media	O
was	O
found	O
to	O
be	O
consistent	O
between	O
day	O
14	O
and	O
day	O
28	O
,	O
indicating	O
that	O
a	O
similar	O
low	O
level	O
of	O
GAG	O
was	O
lost	O
to	O
the	O
media	O
throughout	O
culture	O
(	O
Figure	O
6D	O
).	O

Sample	O
size	O
of	O
n	O
=	O
3	O
per	O
group	O
was	O
used	O
in	O
all	O
cases	O
.	O

3	O
.	O
6	O
.	O

Gene	O
Expression	O

Analysis	O
of	O
gene	O
expression	O
was	O
performed	O
to	O
test	O
the	O
effects	O
of	O
materials	O
on	O
gene	O
expression	O
in	O
the	O
system	O
.	O
COL2A1	B-GP
and	O
ACAN	B-GP
levels	O
were	O
tested	O
to	O
assess	O
positive	O
chondrogenesis	O
,	O
with	O
COL1A1	B-GP
and	O
COL10A1	B-GP
serving	O
as	O
indicators	O
for	O
fibrocartilage	O
development	O
and	O
chondrocyte	O
hypertrophy	O
/	O
calcification	O
.	O

Gene	O
expression	O
results	O
showed	O
an	O
influence	O
of	O
HAMA	O
,	O
with	O
a	O
decrease	O
in	O
COL1A1	B-GP
(	O
Figure	O
7A	O
),	O
increase	O
in	O
COL2A1	B-GP
(	O
Figure	O
7B	O
),	O
increase	O
in	O
ACAN	B-GP
(	O
Figure	O
7C	O
)	O
and	O
decrease	O
in	O
COL10A1	B-GP
(	O
Figure	O
7D	O
)	O
in	O
HAMA	O
-	O
containing	O
gels	O
.	O

Whilst	O
some	O
slight	O
variability	O
existed	O
within	O
HAMA	O
-	O
free	O
and	O
HAMA	O
-	O
containing	O
gels	O
,	O
no	O
significant	O
difference	O
was	O
detected	O
with	O
the	O
presence	O
of	O
HAP	O
.	O

3	O
.	O
7	O
.	O

Immunofluorescence	O

Immunofluorescence	O
was	O
conducted	O
on	O
sections	O
to	O
corroborate	O
gene	O
expression	O
data	O
on	O
an	O
ECM	O
-	O
protein	O
level	O
.	O

Staining	O
was	O
done	O
for	O
collagen	B-GP
I	I-GP
and	O
II	O
(	O
I	O
red	O
,	O
II	O
green	O
,	O
Figure	O
8A	O
–	O
D	O
),	O
aggrecan	B-GP
(	O
Figure	O
8E	O
–	O
H	O
)	O
and	O
collagen	B-GP
X	I-GP
(	O
Figure	O
8I	O
–	O
L	O
)	O
performed	O
on	O
all	O
groups	O
(	O
top	O
row	O
:	O
GelMA	O
-	O
ALG	O
,	O
second	O
row	O
:	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
,	O
third	O
row	O
:	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
,	O
bottom	O
row	O
:	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
).	O

Chondrocyte	O
spreading	O
and	O
high	O
collagen	B-GP
I	I-GP
expression	O
was	O
clearly	O
observable	O
at	O
the	O
surface	O
of	O
the	O
gels	O
compared	O
with	O
the	O
interior	O
.	O

Within	O
the	O
center	O
of	O
the	O
gels	O
a	O
chondrogenic	O
response	O
was	O
confirmed	O
through	O
a	O
more	O
rounded	O
chondrocyte	O
morphology	O
and	O
collagen	B-GP
II	I-GP
staining	O
.	O

Aggrecan	B-GP
staining	O
was	O
found	O
throughout	O
the	O
matrix	O
of	O
all	O
groups	O
as	O
well	O
as	O
at	O
the	O
surface	O
.	O

Collagen	B-GP
X	I-GP
appeared	O
present	O
throughout	O
the	O
ECM	O
,	O
with	O
strongest	O
staining	O
apparent	O
at	O
the	O
HAP	O
interface	O
(	O
as	O
seen	O
in	O
the	O
lowest	O
area	O
of	O
panel	O
K	O
).	O

Images	O
were	O
taken	O
of	O
the	O
deep	O
portion	O
of	O
hydrogels	O
at	O
the	O
periphery	O
of	O
the	O
scaffold	O
meshes	O
,	O
with	O
surface	O
images	O
inset	O
.	O

Overall	O
a	O
chondrogenic	O
effect	O
of	O
HAMA	O
was	O
observed	O
,	O
with	O
a	O
very	O
limited	O
influence	O
of	O
HAP	O
.	O

Isotype	O
negative	O
controls	O
in	O
the	O
form	O
of	O
mouse	B-OG
IgG	B-GP
were	O
used	O
to	O
assess	O
non	O
-	O
specific	O
staining	O
(	O
data	O
not	O
shown	O
).	O

4	O
.	O

Discussion	O

HAP	O
-	O
containing	O
(	O
gelMA	O
-	O
ALG	O
/	O
HAP	O
,	O
gelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
)	O
and	O
HAP	O
-	O
free	O
(	O
gelMA	O
-	O
ALG	O
,	O
gelMA	O
/	O
HAMA	O
-	O
ALG	O
)	O
scaffolds	O
were	O
produced	O
through	O
3D	O
plotting	O
of	O
alginate	O
or	O
alginate	O
/	O
hydroxyapatite	O
paste	O
and	O
photocrosslinked	O
with	O
hydrogels	O
to	O
form	O
hybrid	O
constructs	O
for	O
evaluation	O
of	O
preliminary	O
osteochondral	O
regeneration	O
.	O

Whilst	O
hydrogels	O
widely	O
appear	O
to	O
give	O
the	O
most	O
desired	O
matrix	O
in	O
terms	O
of	O
hypoxia	O
,	O
high	O
fluid	O
content	O
,	O
ease	O
of	O
diffusivity	O
and	O
tailorable	O
mechanical	O
properties	O
,	O
there	O
is	O
no	O
clear	O
consensus	O
on	O
what	O
type	O
of	O
material	O
is	O
most	O
desirable	O
for	O
osteochondral	O
regeneration	O
[	O
13	O
,	O
25	O
,	O
26	O
,	O
27	O
,	O
28	O
,	O
29	O
].	O

Herein	O
we	O
presented	O
a	O
hybrid	O
construct	O
containing	O
both	O
chondro	O
-	O
and	O
osteo	O
-	O
conductive	O
materials	O
.	O

However	O
,	O
it	O
is	O
a	O
preliminary	O
design	O
which	O
does	O
not	O
afford	O
the	O
clear	O
material	O
-	O
driven	O
effects	O
we	O
may	O
observe	O
when	O
using	O
homogeneous	O
structures	O
.	O

Khanarian	O
and	O
colleagues	O
present	O
such	O
a	O
construct	O
,	O
showing	O
that	O
in	O
a	O
large	O
volume	O
scaffold	O
with	O
a	O
homogenous	O
composition	O
,	O
the	O
potential	O
of	O
hydroxyapatite	O
as	O
a	O
ZCC	O
material	O
is	O
clearly	O
shown	O
[	O
27	O
].	O

In	O
this	O
study	O
,	O
alginate	O
was	O
used	O
as	O
the	O
hydrogel	O
component	O
of	O
the	O
ceramic	O
/	O
hydrogel	O
scaffold	O
,	O
although	O
unlike	O
in	O
our	O
study	O
,	O
the	O
construct	O
was	O
not	O
formed	O
using	O
3D	O
plotting	O
.	O

Alginate	O
has	O
previously	O
been	O
shown	O
to	O
be	O
both	O
supportive	O
of	O
chondrocytes	O
in	O
culture	O
[	O
30	O
,	O
31	O
,	O
32	O
],	O
and	O
valid	O
as	O
a	O
tissue	O
engineering	O
vessel	O
[	O
33	O
,	O
34	O
,	O
35	O
].	O

It	O
also	O
has	O
desirable	O
viscous	O
properties	O
for	O
3D	O
plotting	O
and	O
ionic	O
crosslinking	O
capabilities	O
that	O
allow	O
for	O
a	O
rapid	O
sol	O
-	O
gel	O
transition	O
.	O

Furthermore	O
,	O
alginate	O
has	O
been	O
shown	O
to	O
be	O
biocompatible	O
and	O
biodegradable	O
,	O
supportive	O
of	O
native	O
chondrocyte	O
morphology	O
and	O
matrix	O
deposition	O
,	O
as	O
well	O
as	O
promoting	O
bone	O
healing	O
in	O
certain	O
cases	O
[	O
36	O
,	O
37	O
];	O
all	O
of	O
which	O
led	O
to	O
our	O
selection	O
of	O
alginate	O
as	O
a	O
component	O
of	O
our	O
ceramic	O
paste	O
.	O

Our	O
team	O
has	O
also	O
recently	O
published	O
work	O
involving	O
a	O
somewhat	O
similar	O
concept	O
to	O
the	O
plotting	O
mechanism	O
presented	O
herein	O
,	O
finding	O
that	O
3D	O
plotting	O
of	O
gelatin	O
/	O
alginate	O
with	O
or	O
without	O
HAP	O
was	O
an	O
efficacious	O
scaffold	O
system	O
,	O
supporting	O
bone	O
marrow	O
stromal	O
cells	O
over	O
21	O
days	O
in	O
vitro	O
[	O
38	O
].	O

Interestingly	O
,	O
the	O
limited	O
chondrocyte	O
hypertrophy	O
we	O
observed	O
(	O
as	O
evidenced	O
by	O
COL10A1	B-GP
expression	O
and	O
immunofluorescent	O
staining	O
)	O
was	O
similar	O
for	O
Khanarian	O
et	O
al	O
.	O
[	O
27	O
],	O
who	O
reported	O
that	O
the	O
exclusive	O
use	O
of	O
deep	O
zone	O
chondrocytes	O
gave	O
a	O
much	O
better	O
result	O
in	O
terms	O
of	O
hypertrophy	O
and	O
mechanical	O
properties	O
when	O
compared	O
with	O
full	O
thickness	O
cells	O
.	O

It	O
may	O
be	O
inferred	O
that	O
subdividing	O
constructs	O
in	O
the	O
future	O
to	O
isolate	O
cell	O
populations	O
may	O
be	O
advantageous	O
.	O

For	O
instance	O
,	O
the	O
calcified	O
layer	O
of	O
the	O
scaffold	O
may	O
be	O
printed	O
with	O
cells	O
included	O
within	O
the	O
paste	O
,	O
and	O
/	O
or	O
a	O
small	O
layer	O
of	O
hydrogel	O
containing	O
deep	O
zone	O
chondrocytes	O
may	O
be	O
photocrosslinked	O
onto	O
the	O
mesh	O
,	O
followed	O
by	O
a	O
layer	O
of	O
hydrogel	O
containing	O
superficial	O
or	O
full	O
thickness	O
chondrocytes	O
for	O
the	O
remainder	O
of	O
the	O
construct	O
.	O

Alternately	O
,	O
the	O
printing	O
of	O
the	O
entire	O
construct	O
may	O
be	O
possible	O
if	O
appropriate	O
material	O
optimizations	O
are	O
performed	O
to	O
ensure	O
structural	O
fidelity	O
.	O

Whilst	O
the	O
material	O
choice	O
is	O
supported	O
by	O
literary	O
evidence	O
and	O
conducive	O
to	O
chondrogenesis	O
,	O
there	O
is	O
a	O
limited	O
effect	O
on	O
calcification	O
that	O
indicates	O
the	O
scaffold	O
system	O
requires	O
further	O
development	O
and	O
characterization	O
.	O

Use	O
of	O
layered	O
constructs	O
has	O
been	O
explored	O
extensively	O
in	O
the	O
literature	O
,	O
with	O
three	O
main	O
methods	O
used	O
:	O
(	O
1	O
)	O
seeding	O
of	O
chondrocytes	O
or	O
neocartilage	O
tissue	O
directly	O
onto	O
a	O
bone	O
scaffold	O
;	O
(	O
2	O
)	O
“	O
assembling	O
”	O
a	O
bilayered	O
scaffold	O
from	O
two	O
components	O
;	O
and	O
(	O
3	O
)	O
forming	O
an	O
“	O
integrated	O
”	O
bilayered	O
scaffold	O
[	O
39	O
].	O

Our	O
approach	O
falls	O
into	O
category	O
3	O
,	O
and	O
is	O
also	O
supported	O
in	O
principle	O
and	O
material	O
choice	O
(	O
alginate	O
)	O
by	O
a	O
study	O
focused	O
on	O
3D	O
plotting	O
of	O
layered	O
scaffolds	O
,	O
where	O
preliminary	O
outcomes	O
show	O
chondrogenesis	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
[	O
13	O
].	O

Data	O
related	O
to	O
enhanced	O
mechanical	O
properties	O
also	O
reinforce	O
the	O
relevance	O
of	O
this	O
work	O
,	O
with	O
Hollenstein	O
et	O
al	O
.,	O
showing	O
improved	O
bone	O
-	O
hydrogel	O
interfacing	O
when	O
a	O
ZCC	O
was	O
included	O
in	O
constructs	O
[	O
25	O
].	O

Whilst	O
all	O
the	O
aforementioned	O
studies	O
delve	O
into	O
innovations	O
within	O
this	O
field	O
,	O
the	O
fact	O
remains	O
that	O
further	O
study	O
is	O
required	O
in	O
order	O
to	O
completely	O
construct	O
a	O
relevant	O
picture	O
of	O
what	O
is	O
required	O
for	O
successful	O
osteochondral	O
regeneration	O
through	O
the	O
implementation	O
of	O
scaffold	O
technologies	O
.	O

Namely	O
,	O
it	O
is	O
difficult	O
to	O
determine	O
which	O
chondrogenic	O
and	O
osteogenic	O
components	O
are	O
most	O
efficacious	O
for	O
the	O
regeneration	O
of	O
a	O
single	O
component	O
.	O

In	O
a	O
combined	O
environment	O
,	O
it	O
is	O
also	O
difficult	O
to	O
determine	O
whether	O
their	O
applicability	O
to	O
the	O
regeneration	O
varies	O
upon	O
combination	O
or	O
is	O
affected	O
by	O
a	O
biphasic	O
system	O
.	O

In	O
our	O
approach	O
we	O
used	O
a	O
chondrogenic	O
medium	O
containing	O
transforming	B-GP
growth	I-GP
factor	I-GP
(	B-GP
TGF	I-GP
)-	I-GP
β3	I-GP
.	O

It	O
has	O
been	O
shown	O
that	O
TGF	B-GP
-	I-GP
β3	I-GP
is	O
involved	O
in	O
both	O
chondrogenic	O
[	O
40	O
]	O
and	O
osteogenic	O
[	O
41	O
,	O
42	O
]	O
differentiation	O
,	O
and	O
hence	O
it	O
was	O
considered	O
as	O
conducive	O
to	O
development	O
in	O
both	O
areas	O
of	O
our	O
construct	O
.	O

Future	O
studies	O
may	O
benefit	O
from	O
an	O
alternate	O
culture	O
approach	O
however	O
,	O
as	O
TGF	B-GP
-	I-GP
β3	I-GP
has	O
been	O
shown	O
to	O
decrease	O
scar	O
tissue	O
formation	O
through	O
the	O
attenuation	O
of	O
collagen	B-GP
type	I-GP
I	I-GP
synthesis	O
;	O
however	O
these	O
effects	O
are	O
largely	O
demonstrated	O
on	O
skin	B-DS
lesions	I-DS
postoperatively	O
and	O
hence	O
in	O
fibroblastic	O
cells	O
[	O
43	O
,	O
44	O
,	O
45	O
].	O

Its	O
effects	O
on	O
collagen	B-GP
type	I-GP
X	I-GP
synthesis	O
are	O
currently	O
undefined	O
and	O
conversely	O
to	O
the	O
above	O
,	O
it	O
has	O
also	O
been	O
observed	O
to	O
stimulate	O
transcription	O
of	O
the	O
COL1A2	B-GP
gene	O
[	O
46	O
].	O

Hence	O
the	O
level	O
to	O
which	O
it	O
may	O
be	O
influential	O
on	O
the	O
development	O
of	O
the	O
ZCC	O
are	O
yet	O
undetermined	O
and	O
require	O
further	O
testing	O
.	O

Overall	O
,	O
in	O
this	O
study	O
we	O
presented	O
a	O
preliminary	O
structure	O
consisting	O
of	O
a	O
mesh	O
scaffold	O
combined	O
with	O
a	O
hydrogel	O
polymer	O
,	O
and	O
show	O
that	O
the	O
combination	O
yields	O
a	O
greater	O
increase	O
in	O
mechanical	O
properties	O
than	O
that	O
of	O
a	O
control	O
scaffold	O
(	O
ALG	O
),	O
and	O
that	O
the	O
use	O
of	O
the	O
ALG	O
/	O
HAP	O
scaffolds	O
does	O
not	O
negatively	O
influence	O
chondrogenic	O
response	O
of	O
chondrocytes	O
in	O
vitro	O
.	O
Limited	O
cytotoxicity	O
was	O
observed	O
on	O
day	O
1	O
from	O
either	O
of	O
the	O
two	O
scaffold	O
types	O
or	O
the	O
gels	O
,	O
as	O
confirmed	O
by	O
fluorescent	O
staining	O
and	O
subsequent	O
image	O
quantification	O
.	O

While	O
viability	O
was	O
not	O
assessed	O
at	O
later	O
time	O
-	O
points	O
,	O
increases	O
in	O
DNA	O
and	O
GAG	O
content	O
indicated	O
that	O
cells	O
remained	O
viable	O
throughout	O
the	O
entire	O
28	O
day	O
culture	O
period	O
.	O

Elastic	O
modulus	O
increased	O
considerably	O
throughout	O
the	O
culture	O
period	O
,	O
with	O
HAMA	O
significantly	O
increasing	O
modulus	O
in	O
ALG	O
groups	O
and	O
the	O
use	O
of	O
ALG	O
/	O
HAP	O
scaffolds	O
increasing	O
modulus	O
relative	O
to	O
the	O
ALG	O
groups	O
.	O

It	O
may	O
be	O
reasoned	O
that	O
the	O
addition	O
of	O
hyaluronic	O
acid	O
within	O
the	O
hydrogel	O
positively	O
influenced	O
both	O
the	O
cell	O
activity	O
throughout	O
the	O
culture	O
period	O
,	O
as	O
well	O
as	O
providing	O
an	O
additional	O
material	O
that	O
is	O
able	O
to	O
crosslink	O
to	O
both	O
its	O
own	O
and	O
to	O
the	O
gelMA	O
network	O
.	O

There	O
was	O
an	O
increased	O
trend	O
in	O
modulus	O
with	O
ALG	O
/	O
HAP	O
,	O
which	O
may	O
be	O
due	O
to	O
the	O
significantly	O
higher	O
density	O
in	O
the	O
scaffold	O
.	O

Scaffold	O
strands	O
were	O
printed	O
with	O
the	O
same	O
diameter	O
nozzle	O
in	O
both	O
cases	O
(	O
ALG	O
and	O
ALG	O
/	O
HAP	O
)	O
and	O
hence	O
with	O
the	O
HAP	O
groups	O
a	O
lesser	O
proportion	O
of	O
water	O
was	O
present	O
in	O
each	O
strand	O
.	O

The	O
HAP	O
content	O
was	O
in	O
fact	O
42	O
%,	O
and	O
hence	O
the	O
concentration	O
of	O
alginate	O
in	O
water	O
would	O
also	O
be	O
higher	O
in	O
the	O
ALG	O
/	O
HAP	O
scaffold	O
strands	O
compared	O
with	O
the	O
ALG	O
alone	O
.	O

However	O
,	O
simultaneously	O
the	O
alginate	O
network	O
integrity	O
may	O
be	O
disturbed	O
by	O
the	O
presence	O
of	O
HAP	O
particles	O
within	O
the	O
construct	O
strands	O
,	O
and	O
any	O
benefit	O
to	O
the	O
increased	O
concentration	O
of	O
ALG	O
within	O
the	O
strand	O
may	O
be	O
mitigated	O
.	O

Finally	O
,	O
if	O
indeed	O
the	O
ALG	O
/	O
HAP	O
scaffold	O
matrix	O
was	O
stiffer	O
than	O
ALG	O
,	O
the	O
increase	O
in	O
overall	O
construct	O
modulus	O
may	O
be	O
caused	O
by	O
a	O
lesser	O
transverse	O
expansion	O
of	O
the	O
scaffolds	O
under	O
load	O
.	O

This	O
hypothesis	O
is	O
supported	O
by	O
Khanarian	O
et	O
al	O
.	O
[	O
27	O
],	O
who	O
demonstrate	O
an	O
increase	O
in	O
modulus	O
of	O
scaffold	O
constructs	O
made	O
entirely	O
from	O
alginate	O
and	O
hydroxyapatite	O
,	O
and	O
hence	O
it	O
may	O
be	O
concluded	O
that	O
the	O
presence	O
of	O
the	O
HAP	O
does	O
in	O
fact	O
influence	O
the	O
stiffness	O
of	O
the	O
construct	O
strands	O
.	O

The	O
mechanical	O
properties	O
obtained	O
herein	O
are	O
over	O
an	O
order	O
of	O
magnitude	O
lower	O
than	O
that	O
of	O
native	O
cartilage	O
tissue	O
,	O
however	O
the	O
mimicry	O
of	O
native	O
values	O
may	O
be	O
not	O
required	O
.	O

The	O
construct	O
must	O
of	O
course	O
be	O
able	O
to	O
withstand	O
the	O
mechanical	O
environment	O
of	O
the	O
joint	O
,	O
but	O
with	O
appropriate	O
stimulus	O
(	O
driven	O
through	O
the	O
neotissue	O
matrix	O
)	O
the	O
matrix	O
deposition	O
of	O
chondrocytes	O
may	O
be	O
encouraged	O
.	O

As	O
this	O
model	O
was	O
cultured	O
in	O
a	O
static	O
environment	O
,	O
the	O
values	O
of	O
modulus	O
are	O
not	O
representative	O
of	O
what	O
would	O
be	O
attainable	O
under	O
compressive	O
loading	O
during	O
culture	O
.	O

This	O
was	O
done	O
however	O
to	O
simplify	O
the	O
process	O
and	O
allow	O
the	O
examination	O
of	O
parameters	O
in	O
a	O
less	O
complex	O
system	O
.	O

It	O
is	O
unclear	O
what	O
mechanical	O
properties	O
are	O
ideal	O
for	O
a	O
tissue	O
engineered	O
cartilage	O
construct	O
,	O
however	O
it	O
is	O
the	O
belief	O
of	O
the	O
authors	O
that	O
this	O
will	O
become	O
clearer	O
as	O
biomaterials	O
research	O
progresses	O
.	O

Examination	O
of	O
GAG	O
and	O
DNA	O
content	O
within	O
the	O
scaffolds	O
showed	O
consistent	O
DNA	O
levels	O
between	O
groups	O
,	O
and	O
a	O
comparable	O
yet	O
significantly	O
different	O
level	O
of	O
GAG	O
secreted	O
between	O
the	O
gelMA	O
and	O
the	O
gelMA	O
/	O
HAMA	O
groups	O
.	O

In	O
all	O
cases	O
HAMA	O
increased	O
the	O
level	O
of	O
GAGs	O
produced	O
,	O
yet	O
the	O
varying	O
of	O
scaffold	O
type	O
from	O
ALG	O
to	O
ALG	O
/	O
HAP	O
failed	O
to	O
have	O
an	O
effect	O
on	O
this	O
metric	O
.	O

It	O
may	O
be	O
that	O
the	O
localization	O
of	O
the	O
scaffolds	O
to	O
the	O
greatest	O
depth	O
of	O
the	O
gels	O
along	O
with	O
their	O
physiologically	O
relevant	O
thickness	O
reduces	O
any	O
potential	O
effects	O
they	O
may	O
have	O
on	O
the	O
majority	O
of	O
the	O
chondrocytes	O
within	O
the	O
gel	O
phase	O
.	O

However	O
,	O
it	O
is	O
clear	O
that	O
inclusion	O
of	O
a	O
prominent	O
glycosaminoglycan	O
such	O
as	O
HA	O
within	O
the	O
gel	O
has	O
a	O
positive	O
effect	O
on	O
chondrogenic	O
differentiation	O
,	O
whilst	O
it	O
is	O
unknown	O
what	O
effect	O
methacrylation	O
of	O
this	O
compound	O
has	O
on	O
its	O
cellular	O
interactions	O
.	O

This	O
data	O
confirms	O
our	O
research	O
group	O
’	O
s	O
previous	O
findings	O
,	O
where	O
HAMA	O
was	O
found	O
to	O
be	O
supportive	O
of	O
chondrogenic	O
differentiation	O
[	O
16	O
].	O

As	O
all	O
GAG	O
data	O
were	O
corrected	O
using	O
cell	O
-	O
free	O
constructs	O
,	O
the	O
influence	O
of	O
HAMA	O
on	O
the	O
GAG	O
assay	O
was	O
negated	O
.	O

PCR	O
data	O
showed	O
a	O
much	O
higher	O
expression	O
of	O
COL1A1	B-GP
and	O
COL10A1	B-GP
in	O
the	O
HAMA	O
-	O
free	O
gels	O
,	O
indicating	O
a	O
fibrocartilaginous	O
phenotype	O
,	O
whilst	O
COL2A1	B-GP
and	O
ACAN	B-GP
expression	O
further	O
supported	O
this	O
conclusion	O
.	O

Higher	O
levels	O
of	O
collagen	B-GP
I	I-GP
and	O
collagen	B-GP
X	I-GP
are	O
indicative	O
of	O
dedifferentiated	O
chondrocytes	O
,	O
with	O
elevated	O
levels	O
observed	O
in	O
gelMA	O
-	O
only	O
gels	O
throughout	O
the	O
literature	O
[	O
16	O
,	O
47	O
].	O

This	O
effect	O
is	O
namely	O
due	O
to	O
the	O
high	O
number	O
of	O
attachment	O
(	O
RGD	O
peptide	O
)	O
sites	O
present	O
on	O
gelatin	O
that	O
strongly	O
promote	O
cell	O
attachment	O
and	O
hence	O
spreading	O
,	O
along	O
with	O
the	O
fact	O
that	O
the	O
polymer	O
is	O
a	O
derivative	O
of	O
largely	O
collagen	B-GP
type	I-GP
I	I-GP
.	O

Higher	O
expression	O
levels	O
of	O
chondrogenically	O
relevant	O
genes	O
such	O
as	O
COL2A1	B-GP
and	O
ACAN	B-GP
were	O
observed	O
in	O
HAMA	O
-	O
containing	O
gels	O
compared	O
against	O
HAMA	O
-	O
free	O
groups	O
.	O

There	O
was	O
no	O
significant	O
effect	O
of	O
ALG	O
/	O
HAP	O
scaffolds	O
on	O
COL10A1	B-GP
expression	O
,	O
although	O
a	O
slight	O
trend	O
was	O
noticeable	O
.	O

It	O
is	O
possible	O
that	O
downregulation	O
of	O
COL1A1	B-GP
and	O
COL10A1	B-GP
in	O
hydrogels	O
containing	O
HAMA	O
was	O
caused	O
by	O
activation	O
of	O
CD44	B-GP
,	O
as	O
in	O
low	O
concentrations	O
hyaluronic	O
acid	O
has	O
been	O
shown	O
to	O
promote	O
chondrogenesis	O
through	O
this	O
pathway	O
[	O
48	O
,	O
49	O
].	O

Immunofluorescence	O
examining	O
protein	O
levels	O
in	O
the	O
matrix	O
indicated	O
similar	O
relationships	O
to	O
PCR	O
,	O
with	O
higher	O
collagen	B-GP
I	I-GP
staining	O
found	O
in	O
HAMA	O
-	O
free	O
gels	O
and	O
stronger	O
collagen	B-GP
II	I-GP
and	O
aggrecan	B-GP
staining	O
observable	O
in	O
HAMA	O
-	O
containing	O
gels	O
.	O

Collagen	B-GP
X	I-GP
staining	O
appeared	O
relatively	O
even	O
throughout	O
the	O
ECM	O
,	O
with	O
gelMA	O
-	O
ALG	O
/	O
HAP	O
showing	O
staining	O
surrounding	O
the	O
lowest	O
region	O
of	O
the	O
scaffold	O
which	O
was	O
the	O
area	O
of	O
interest	O
in	O
this	O
case	O
(	O
Figure	O
8K	O
).	O

The	O
levels	O
in	O
all	O
groups	O
did	O
not	O
vary	O
enough	O
to	O
show	O
conclusive	O
effects	O
,	O
however	O
trends	O
appeared	O
to	O
support	O
PCR	O
findings	O
and	O
hence	O
are	O
also	O
explainable	O
and	O
in	O
support	O
of	O
the	O
previously	O
listed	O
reasoning	O
.	O

In	O
all	O
cases	O
isotype	O
negative	O
controls	O
consisted	O
of	O
mouse	B-OG
IgG	B-GP
and	O
verified	O
no	O
non	O
-	O
specific	O
staining	O
of	O
matrix	O
occurred	O
.	O

In	O
line	O
with	O
previous	O
results	O
[	O
25	O
,	O
27	O
,	O
50	O
],	O
we	O
found	O
a	O
slight	O
increase	O
in	O
modulus	O
after	O
culture	O
of	O
ALG	O
/	O
HAP	O
scaffolds	O
,	O
with	O
comparable	O
trends	O
in	O
cell	O
free	O
conditions	O
.	O

On	O
the	O
other	O
hand	O
,	O
whilst	O
others	O
have	O
shown	O
that	O
inclusion	O
of	O
bioactive	O
glass	O
increases	O
GAG	O
in	O
hydrogels	O
[	O
28	O
],	O
we	O
found	O
ALG	O
/	O
HAP	O
to	O
have	O
a	O
limited	O
effect	O
in	O
our	O
system	O
.	O

As	O
the	O
ALG	O
/	O
HAP	O
scaffolds	O
were	O
intact	O
at	O
the	O
time	O
of	O
crosslinking	O
and	O
appeared	O
to	O
remain	O
intact	O
at	O
day	O
28	O
of	O
culture	O
,	O
it	O
may	O
be	O
postulated	O
that	O
limited	O
diffusion	O
of	O
HAP	O
occurred	O
throughout	O
the	O
culture	O
period	O
.	O

It	O
may	O
thus	O
be	O
inferred	O
that	O
culture	O
in	O
a	O
system	O
such	O
as	O
a	O
compression	O
bioreactor	O
may	O
further	O
accentuate	O
the	O
observed	O
trends	O
and	O
bring	O
them	O
to	O
a	O
significant	O
and	O
notable	O
level	O
.	O

With	O
appropriate	O
structural	O
modifications	O
,	O
perfusion	O
bioreactors	O
may	O
also	O
be	O
suitable	O
for	O
this	O
application	O
[	O
36	O
].	O

Overall	O
we	O
showed	O
that	O
the	O
combination	O
of	O
gelMA	O
and	O
HAMA	O
with	O
a	O
HAP	O
/	O
ALG	O
scaffold	O
system	O
is	O
viable	O
for	O
cells	O
,	O
maintains	O
positive	O
chondrogenesis	O
and	O
provides	O
a	O
platform	O
for	O
the	O
exploration	O
of	O
innovation	O
into	O
such	O
scaffold	O
technologies	O
.	O

5	O
.	O

Conclusions	O

Scaffolds	O
comprising	O
human	B-OG
articular	O
chondrocyte	O
-	O
containing	O
hydrogels	O
(	O
GelMA	O
or	O
GelMA	O
/	O
HAMA	O
)	O
crosslinked	O
through	O
3D	O
printed	O
paste	O
meshes	O
(	O
alginate	O
or	O
alginate	O
/	O
HAP	O
)	O
were	O
cultured	O
for	O
28	O
days	O
under	O
chondrogenic	O
conditions	O
in	O
vitro	O
.	O

No	O
cytotoxicity	O
was	O
observed	O
from	O
scaffold	O
components	O
.	O

Incorporation	O
of	O
HAMA	O
into	O
hydrogels	O
improved	O
chondrogenesis	O
.	O

The	O
use	O
of	O
ALG	O
/	O
HAP	O
versus	O
ALG	O
did	O
not	O
encourage	O
the	O
formation	O
of	O
a	O
ZCC	O
,	O
however	O
changes	O
in	O
scaffold	O
design	O
,	O
such	O
as	O
incorporation	O
of	O
a	O
larger	O
amount	O
of	O
HAP	O
,	O
or	O
use	O
of	O
bioreactor	O
systems	O
may	O
be	O
used	O
in	O
the	O
future	O
to	O
expand	O
on	O
this	O
system	O
.	O

Schematic	O
illustration	O
of	O
the	O
groups	O
included	O
in	O
the	O
study	O
.	O
Groups	O
used	O
in	O
the	O
study	O
comprised	O
(	O
A	O
):	O
gelatin	O
methacrylamide	O
(	O
GelMA	O
)	O
with	O
an	O
alginate	O
(	O
ALG	O
)	O
paste	O
scaffold	O
;	O
(	O
B	O
):	O
GelMA	O
with	O
hyaluronic	O
acid	O
methacrylate	O
(	O
HAMA	O
)	O
with	O
an	O
ALG	O
paste	O
scaffold	O
;	O
(	O
C	O
):	O
GelMA	O
with	O
a	O
combined	O
alginate	O
and	O
hydroxyapatite	O
paste	O
(	O
ALG	O
/	O
HAP	O
)	O
scaffold	O
;	O
and	O
(	O
D	O
):	O
GelMA	O
/	O
HAMA	O
with	O
an	O
ALG	O
/	O
HAP	O
scaffold	O
.	O

Images	O
of	O
hydrogel	O
/	O
scaffold	O
hybrid	O
constructs	O
.	O

(	O
A	O
)	O
photo	O
illustrating	O
ALG	O
/	O
HAP	O
scaffolds	O
crosslinked	O
within	O
GelMA	O
hydrogels	O
on	O
day	O
1	O
and	O
(	O
B	O
)	O
day	O
28	O
.	O

Scale	O
bar	O
4	O
mm	O
;	O
(	O
C	O
,	O
D	O
)	O
scaffolds	O
imaged	O
using	O
micro	O
-	O
computed	O
tomography	O
(	O
µCT	O
),	O
with	O
thresholding	O
used	O
to	O
isolate	O
high	O
density	O
components	O
(	O
colored	O
scale	O
illustrates	O
mg	O
·	O
cm	O
−	O
3	O
of	O
HAP	O
);	O
(	O
C	O
)	O
GelMA	O
-	O
ALG	O
and	O
(	O
D	O
)	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
illustrated	O
,	O
scale	O
bar	O
1	O
mm	O
as	O
indicated	O
.	O

Proton	O
Nuclear	O
Magnetic	O
Resonance	O
(	O
1H	O
NMR	O
)	O
spectra	O
of	O
hydrogels	O
.	O

(	O
A	O
):	O
gelatin	O
;	O
(	O
B	O
):	O
gelatin	O
methacrylamide	O
(	O
GelMA	O
);	O
(	O
C	O
):	O
hyaluronic	O
acid	O
(	O
HA	O
);	O
(	O
D	O
):	O
hyaluronic	O
acid	O
methacrylate	O
(	O
HAMA	O
).	O

Areas	O
of	O
interest	O
are	O
inset	O
within	O
each	O
frame	O
.	O

Aromatic	O
peaks	O
in	O
gelatin	O
/	O
GelMA	O
are	O
present	O
at	O
~	O
chemical	O
shift	O
(	O
δ	O
)	O
7	O
.	O
4	O
ppm	O
,	O
with	O
the	O
two	O
free	O
protons	O
on	O
the	O
methacrylate	O
groups	O
present	O
at	O
δ	O
5	O
.	O
6	O
and	O
δ	O
5	O
.	O
8	O
ppm	O
respectively	O
.	O

In	O
HA	O
,	O
the	O
peak	O
from	O
the	O
n	O
-	O
acetyl	O
protons	O
is	O
present	O
at	O
~	O
δ	O
2	O
.	O
1	O
ppm	O
,	O
with	O
the	O
methacrylate	O
protons	O
used	O
for	O
degree	O
of	O
functionalization	O
(	O
DOF	O
)	O
measurements	O
present	O
in	O
HAMA	O
at	O
δ	O
5	O
.	O
8	O
and	O
δ	O
6	O
.	O
3	O
ppm	O
.	O

Cell	O
viability	O
in	O
hydrogel	O
groups	O
on	O
day	O
1	O
of	O
culture	O
.	O

Images	O
and	O
quantitated	O
data	O
of	O
cell	O
viability	O
measured	O
using	O
FDA	O
/	O
PI	O
assay	O
on	O
day	O
1	O
of	O
culture	O
.	O

Quantification	O
and	O
image	O
analysis	O
was	O
performed	O
using	O
ImageJ	O
.	O

(	O
A	O
):	O
GelMA	O
-	O
ALG	O
;	O
(	O
B	O
):	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
;	O
(	O
C	O
):	O
GelMA	O
/	O
ALG	O
-	O
HAP	O
;	O
(	O
D	O
):	O
GelMA	O
-	O
HAMA	O
/	O
ALG	O
-	O
HAP	O
;	O
(	O
E	O
):	O
quantified	O
viability	O
from	O
n	O
=	O
3	O
samples	O
per	O
group	O
.	O

Scale	O
bar	O
200	O
µm	O
.	O

Mechanical	O
testing	O
results	O
showing	O
compressive	O
elastic	O
modulus	O
.	O

Elastic	O
modulus	O
of	O
samples	O
on	O
days	O
1	O
and	O
28	O
of	O
culture	O
(	O
n	O
=	O
3	O
per	O
group	O
)	O
with	O
(	O
A	O
):	O
cell	O
-	O
free	O
and	O
(	O
B	O
):	O
cell	O
-	O
containing	O
gels	O
shown	O
separately	O
.	O

The	O
four	O
groups	O
in	O
each	O
time	O
point	O
were	O
compared	O
separately	O
to	O
the	O
second	O
time	O
point	O
,	O
with	O
upper	O
case	O
Roman	O
numerals	O
used	O
for	O
day	O
1	O
and	O
lower	O
case	O
for	O
day	O
28	O
.	O

When	O
groups	O
share	O
Roman	O
numerals	O
they	O
are	O
statistically	O
similar	O
.	O

Bars	O
with	O
stars	O
indicate	O
t	O
-	O
test	O
comparison	O
results	O
between	O
one	O
group	O
across	O
two	O
time	O
points	O
.	O

DNA	O
and	O
GAG	O
content	O
in	O
constructs	O
over	O
the	O
culture	O
period	O
.	O

(	O
A	O
):	O
comparison	O
of	O
day	O
1	O
and	O
day	O
28	O
results	O
of	O
GAG	O
content	O
(	O
µg	O
)	O
per	O
gel	O
wet	O
weight	O
(	O
mg	O
);	O
(	O
B	O
):	O
DNA	O
content	O
(	O
µg	O
)	O
per	O
gel	O
;	O
(	O
C	O
):	O
GAG	O
content	O
(	O
g	O
)	O
per	O
DNA	O
content	O
(	O
g	O
)	O
in	O
gels	O
and	O
(	O
D	O
):	O
GAG	O
concentration	O
in	O
media	O
(	O
µg	O
·	O
mL	O
−	O
1	O
)	O
on	O
days	O
14	O
and	O
28	O
of	O
culture	O
.	O

The	O
four	O
groups	O
in	O
each	O
time	O
point	O
were	O
compared	O
separately	O
to	O
the	O
second	O
time	O
point	O
,	O
with	O
upper	O
case	O
Roman	O
numerals	O
used	O
for	O
day	O
1	O
and	O
lower	O
case	O
for	O
day	O
28	O
.	O

When	O
groups	O
share	O
Roman	O
numerals	O
they	O
are	O
statistically	O
similar	O
.	O

Bars	O
with	O
stars	O
indicate	O
t	O
-	O
test	O
comparison	O
results	O
between	O
one	O
group	O
across	O
two	O
time	O
points	O
.	O

All	O
groups	O
have	O
n	O
=	O
3	O
samples	O
.	O

In	O
all	O
cases	O
cell	O
-	O
free	O
constructs	O
were	O
used	O
to	O
correct	O
for	O
any	O
material	O
-	O
based	O
content	O
potentially	O
interfering	O
with	O
the	O
GAG	O
measurements	O
.	O

Gene	O
expression	O
data	O
for	O
the	O
four	O
groups	O
from	O
day	O
28	O
samples	O
.	O

The	O
four	O
genes	O
that	O
were	O
analyzed	O
were	O
(	O
A	O
):	O
COL1A1	O
;	O
(	O
B	O
):	O
COL2A1	O
;	O
(	O
C	O
):	O
ACAN	O
and	O
(	O
D	O
):	O
COL10A1	O
on	O
day	O
28	O
of	O
cell	O
culture	O
shown	O
as	O
2	O
−	O
ΔCt	O
value	O
(	O
after	O
log2	O
conversion	O
).	O

Statistical	O
analysis	O
was	O
performed	O
on	O
log2	O
data	O
with	O
each	O
group	O
containing	O
n	O
=	O
3	O
samples	O
.	O

A	O
Dunnet	O
’	O
s	O
T3	O
post	O
-	O
hoc	O
test	O
was	O
used	O
to	O
compare	O
means	O
,	O
with	O
p	O
<	O
0	O
.	O
05	O
taken	O
as	O
significant	O
.	O

Shared	O
Roman	O
numerals	O
indicate	O
statistical	O
similarity	O
between	O
gel	O
groups	O
.	O

Immunofluorescence	O
images	O
illustrating	O
deep	O
and	O
surface	O
sections	O
.	O

Staining	O
of	O
collagen	O
I	O
(	O
red	O
),	O
collagen	O
II	O
(	O
green	O
),	O
aggrecan	O
(	O
green	O
)	O
and	O
collagen	O
X	O
(	O
green	O
)	O
was	O
performed	O
on	O
constructs	O
from	O
all	O
groups	O
on	O
day	O
28	O
(	O
as	O
indicated	O
;	O
DAPI	O
nuclei	O
staining	O
in	O
light	O
blue	O
);	O
(	O
A	O
,	O
E	O
,	O
I	O
):	O
GelMA	O
-	O
ALG	O
;	O
(	O
B	O
,	O
F	O
,	O
J	O
):	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
;	O
(	O
C	O
,	O
G	O
,	O
K	O
):	O
GelMA	O
-	O
ALG	O
/	O
HAP	O
and	O
(	O
D	O
,	O
H	O
,	O
L	O
):	O
GelMA	O
/	O
HAMA	O
-	O
ALG	O
/	O
HAP	O
.	O

Images	O
were	O
taken	O
from	O
the	O
deep	O
hydrogel	O
zone	O
near	O
to	O
the	O
ALG	O
or	O
ALG	O
/	O
HAP	O
scaffold	O
,	O
with	O
surface	O
images	O
inset	O
;	O
scale	O
bar	O
50	O
µm	O
.	O

